69.57
Ge Healthcare Technologies Inc stock is traded at $69.57, with a volume of 3.12M.
It is down -1.11% in the last 24 hours and up +9.58% over the past month.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
See More
Previous Close:
$70.35
Open:
$71.1
24h Volume:
3.12M
Relative Volume:
0.80
Market Cap:
$31.42B
Revenue:
$20.98B
Net Income/Loss:
$1.98B
P/E Ratio:
16.66
EPS:
4.177
Net Cash Flow:
$1.52B
1W Performance:
+5.83%
1M Performance:
+9.58%
6M Performance:
-4.96%
1Y Performance:
-5.19%
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Name
Ge Healthcare Technologies Inc
Sector
Industry
Phone
833-735-1139
Address
500 WEST MONROE STREET, CHICAGO
Compare GEHC vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
GEHC
Ge Healthcare Technologies Inc
|
69.57 | 31.42B | 20.98B | 1.98B | 1.52B | 4.177 |
|
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-26 | Initiated | Barclays | Overweight |
| Sep-22-26 | Initiated | Needham | Buy |
| Jul-09-26 | Initiated | BMO Capital Markets | Market Perform |
| Jun-23-26 | Initiated | RBC Capital Mkts | Outperform |
| May-21-26 | Upgrade | UBS | Sell → Neutral |
| Apr-30-26 | Downgrade | Goldman | Buy → Neutral |
| Jan-15-26 | Downgrade | UBS | Neutral → Sell |
| Oct-13-25 | Initiated | Barclays | Equal Weight |
| Oct-07-25 | Downgrade | Citigroup | Buy → Neutral |
| May-05-25 | Upgrade | UBS | Sell → Neutral |
| Mar-11-25 | Upgrade | Goldman | Neutral → Buy |
| Jan-08-25 | Upgrade | Jefferies | Hold → Buy |
| Sep-26-24 | Downgrade | UBS | Neutral → Sell |
| Sep-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-09-24 | Initiated | JP Morgan | Neutral |
| Aug-06-24 | Initiated | Stifel | Buy |
| May-30-24 | Initiated | Goldman | Neutral |
| Feb-15-24 | Initiated | HSBC Securities | Buy |
| Feb-12-24 | Upgrade | UBS | Sell → Neutral |
| Nov-30-23 | Initiated | Jefferies | Hold |
| Nov-27-23 | Downgrade | UBS | Neutral → Sell |
| Sep-19-23 | Initiated | Citigroup | Buy |
| Aug-25-23 | Initiated | Argus | Buy |
| Aug-16-23 | Initiated | Wells Fargo | Overweight |
| Jul-31-23 | Initiated | BofA Securities | Neutral |
| Jun-27-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-16-23 | Initiated | Oppenheimer | Outperform |
| Apr-26-23 | Initiated | UBS | Neutral |
| Apr-19-23 | Initiated | Piper Sandler | Overweight |
| Apr-10-23 | Initiated | BTIG Research | Neutral |
| Mar-13-23 | Initiated | Evercore ISI | Outperform |
| Feb-17-23 | Initiated | Mizuho | Buy |
| Jan-19-23 | Initiated | Redburn | Buy |
View All
Ge Healthcare Technologies Inc Stock (GEHC) Latest News
Vaso Stock Surges 149% in a Year: What's Behind the Rally? - Zacks Investment Research
ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum? - Zacks Investment Research
Digital X-ray MarketGlobal and Regional Analysis and Forecast, 2026-2036 | Mobile Imaging, AI Workflows, and Detector Innovation Drive Growth to $9.90 Billion - GlobeNewswire Inc.
Global Mobile X-ray Systems Market Analysis and Forecast, 2026-2036 | AI-Enabled Digital Imaging and Asia-Pacific Growth Drive a $4.00 Billion Market by 2036 - GlobeNewswire Inc.
Global Mobile C-Arm Market Analysis and Forecast, 2026-2036 | Market to Reach $3.71 Billion as Minimally Invasive Surgery, AI, and 3D Imaging Drive 5.35% CAGR - GlobeNewswire Inc.
Healthcare: Stocks Had a Great Q3, as Defensive Nature and Steady Innovation Drew Interest - Morningstar
Marjorie Taylor Greene Stock Trades and Disclosures - TechGraph
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
GE HealthCare stock pre-market at EUR 57.22: minus 0.10 percent - ad-hoc-news.de
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - GlobeNewswire Inc.
GEHC vs. SYK: Which Stock Should Value Investors Buy Now? - Zacks Investment Research
GE HealthCare Technologies (NasdaqGS:GEHC) Stock Forecast & Analyst Predictions - Simply Wall Street
GE HealthCare (GEHC) Upgraded to Buy: Here's Why - Zacks Investment Research
GE HealthCare stock pre-market at EUR 58.59: minus 0.02 percent - AD HOC NEWS
GE HealthCare Technologies (GEHC) Stock Price, News & Analysis - Stock Titan
GE HealthCare Technologies Inc. (GEHC) Stock Price, News, Quote & History - Yahoo! Finance Canada
GE HealthCare announces cash dividend increase for third quarter of 2026 - Voice of Alexandria
GE HealthCare announces cash dividend increase for third quarter of 2026 - Yahoo Finance
AT&T CFO to join GE HealthCare (Nasdaq: GEHC) board in 2027 - Stock Titan
GE HealthCare Technologies Inc.Common Stock (NQ: GEHC - The Chronicle-Journal
GEHC Stock Price Today - CoinDesk
GE HealthCare (GEHC) grants CFO options and 75K RSUs - Stock Titan
GE HealthCare CFO William K. Grogan Awarded RSUs and Stock Options on September 14, 2026 - Kalkine Media
GE HealthCare is said to near $1B Sofie Biosciences deal (GEHC:NASDAQ) - Seeking Alpha
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports - whbl.com
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports - WTVB
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports - Reuters
GE HealthCare stock holds near $64 after upbeat July results - ad-hoc-news.de
GE HealthCare, Leo Cancer Care to Collaborate on Imaging, Radiation Therapy Workflows - Imaging Technology News
Is GE HealthCare Stock Underperforming the Nasdaq? - inkl
GE HealthCare and RSNA bring leading cancer imaging expertise to Africa to improve access to cancer care - Zawya
Image Guided Therapy Becomes First Office-Based Lab to Install GE HealthCare's Allia(TM) Moveo - Yahoo Finance
Enterprise Imaging Solutions Market Set to Hit USD 6.69 Billion by 2035, Growing at a CAGR of 11.18%SNS Insider - GlobeNewswire Inc.
GE HealthCare Technologies Inc. stock falls Thursday, underperforms market - MarketWatch
GE HealthCare stock slips as StarGuide GX clearance and Wells Fargo outlook shape sentiment - ad-hoc-news.de
GE HealthCare stock heads into the open after a September 9 slide - ad-hoc-news.de
GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market - MarketWatch
GE HealthCare at Wells Fargo conference: backlog and margins build By Investing.com - Investing.com Nigeria
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance - Yahoo Finance
GE HealthCare at Wells Fargo conference: backlog and margins build By Investing.com - Investing.com India
Transcript : GE HealthCare Technologies Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 10 - marketscreener.com
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors? - The Motley Fool
GE HealthCare's StarGuide GX 4D SPECT/CT Now FDA 510(k) Pending - Imaging Technology News
GE HealthCare aims to advance a new era in theranostics with Sta - GuruFocus
A Look at GE HealthCare Technologies Inc (GEHC) After 3.0% Decli - GuruFocus
GE HealthCare Technologies Inc. stock falls Tuesday, underperforms market - MarketWatch
GE HealthCare Technologies Corporate Secretary Jimenez Frank R Forfeits 1,480 Shares at $70.56 on September 3, 2026 - Kalkine Media
Vaso Gains More Than 65% in Three Months: What's Driving the Stock? - Zacks Investment Research
GE HealthCare Files 510(k) for StarGuide GX 4D SPECT/CT - Medical Product Outsourcing
GE HealthCare aims to advance a new era in theranostics with StarGuide™ GX 4D SPECT/CT, now 510(k) pending with the U.S. FDA - Rutland Herald
Ge Healthcare Technologies Inc Stock (GEHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ge Healthcare Technologies Inc Stock (GEHC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hochman Rodney F | Director |
May 12 '26 |
Buy |
62.03 |
1,618 |
100,365 |
1,618 |
| Yang Watkin Phoebe L. | Director |
May 08 '26 |
Buy |
63.01 |
1,000 |
63,006 |
13,702 |
| Stromberg William J | Director |
May 06 '26 |
Buy |
61.69 |
1,000 |
61,689 |
15,330 |
| CULP H LAWRENCE JR | Director |
May 06 '26 |
Buy |
61.88 |
80,805 |
5,000,076 |
151,207 |
| SACCARO JAMES | Chief Financial Officer |
May 01 '26 |
Buy |
60.60 |
3,310 |
200,585 |
87,471 |
| Arduini Peter J | President and CEO |
Apr 30 '26 |
Buy |
59.92 |
4,169 |
249,827 |
259,424 |
| Jimenez Frank R | GC & Corporate Secretary |
Apr 30 '26 |
Buy |
60.45 |
1,750 |
105,788 |
93,932 |
| Kenneth Stacherski | Former Officer |
Nov 24 '25 |
Proposed Sale |
77.00 |
4,585 |
353,045 |
0 |
| Kenneth Stacherski | Former Officer |
Oct 27 '25 |
Proposed Sale |
78.95 |
4,585 |
361,993 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):